Veterinary Medicines

RISPOVAL 3 BRSV PI3 BVD LYOPHILISATE AND SUSPENSION FOR SUSPENSION FOR INJECTION FOR CATTLE

Authorised
  • Bovine parainfluenza virus 3, strain RLB103, Live
  • Bovine viral diarrhoea virus 1, strain 5960, Inactivated
  • Bovine viral diarrhoea virus 1, strain 6309, Inactivated
  • Bovine respiratory syncytial virus, strain 375, Live
Download as PDF

Product identification

Medicine name:
RISPOVAL 3 BRSV PI3 BVD LYOPHILISATE AND SUSPENSION FOR SUSPENSION FOR INJECTION FOR CATTLE
RISPOVAL 3 RS PI3 BVD LYOPHILISAT ET SUSPENSION POUR SUSPENSION INJECTABLE POUR BOVINS
Active substance:
  • Bovine parainfluenza virus 3, strain RLB103, Live
  • Bovine viral diarrhoea virus 1, strain 5960, Inactivated
  • Bovine viral diarrhoea virus 1, strain 6309, Inactivated
  • Bovine respiratory syncytial virus, strain 375, Live
Target species:
  • Cattle
Route of administration:
  • Intramuscular use

Product details

Active substance and strength:
  • Bovine parainfluenza virus 3, strain RLB103, Live
    100000.00
    50% cell culture infectious dose
    /
    1.00
    Dose
  • Bovine viral diarrhoea virus 1, strain 5960, Inactivated
    3.00
    log2 serum neutralising unit(s)
    /
    1.00
    Dose
  • Bovine viral diarrhoea virus 1, strain 6309, Inactivated
    3.00
    log2 serum neutralising unit(s)
    /
    1.00
    Dose
  • Bovine respiratory syncytial virus, strain 375, Live
    100000.00
    50% cell culture infectious dose
    /
    1.00
    Dose
Pharmaceutical form:
  • Lyophilisate and suspension for suspension for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Cattle
      • All relevant tissues
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI02AH
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • France
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application - New active substance (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Zoetis France
Marketing authorisation date:
Manufacturing sites for batch release:
  • Zoetis Belgium
Responsible authority:
  • French Agency For Food, Environmental And Occupational Health & Safety
Authorisation number:
  • FR/V/1611855 9/2003
Date of authorisation status change:
Reference member state:
  • France
Procedure number:
  • FR/V/0146/001
Concerned member states:
  • Belgium
  • Bulgaria
  • Czechia
  • Estonia
  • Germany
  • Hungary
  • Ireland
  • Latvia
  • Lithuania
  • Luxembourg
  • Netherlands
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Slovenia
  • Spain
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 22/05/2024
Download

Combined File of all Documents

English (PDF)
Published on: 24/01/2024
Download

Package Leaflet and Labelling

This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 15/10/2025
Download